Caldwell & Orkin’s Labcorp LH Stock Holding History

Caldwell & Orkin’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,074	Closed	-$441K	–	92
2015 Q1	$441K	Buy	+4,074	New	+$419K	0.25%	77

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Caldwell & Orkin's LH Position: Q2 2015 in Review

Caldwell & Orkin sold out of Labcorp (LH) in Q2 2015, closing a stake of 4,074 shares — an estimated $441K sold.

Caldwell & Orkin first reported a position in LH in Q1 2015 and held it in 1 quarter. The position peaked at $441K in Q1 2015. 616 funds tracked by Wall St. Rank hold LH as of Q2 2015.

Caldwell & Orkin reported no remaining Labcorp position as of Q2 2015 after selling out during the quarter.
Caldwell & Orkin sold 4,074 Labcorp shares in Q2 2015, an estimated $441K.
Caldwell & Orkin first reported a position in Labcorp in Q1 2015 and held it in 1 quarter.
Caldwell & Orkin's Labcorp position peaked at $441K in Q1 2015.
616 funds tracked by Wall St. Rank held Labcorp as of Q2 2015.

Based on Caldwell & Orkin's 13F filing for Q2 2015, filed 7 Aug 2015.